A regional analysis of primary drugs used by patients in treatment highlights distinctive patterns. Opioids are a major concern in Europe, Africa, and America (led by Europe at 45%). Asia Pacific faces a significant challenge with amphetamine-type stimulants (47% of cases). Cannabis dominates in Oceania and Africa, while cocaine's impact varies across the Americas and Europe. Tailoring region-specific public health strategies is crucial to address these diverse drug challenges.